$116.67
0.030.03%
At close: Aug 24, 5:00 PM EST
$116.67
N/A
After Hours: 4:03 PM EST
Abbott Laboratories Earnings Estimates
ABTNYSE
Abbott Laboratories Earnings Estimates, EPS & Revenue | NYSE:ABT
Abbott Laboratories (ABT) is scheduled to report Q3 earnings on October 14, 2026. Analysts estimate EPS of $1.42 and quarterly revenue of $12.97B.
In the most recent quarter (Q2), Abbott Laboratories reported EPS of $1.31, beating estimates of $1.28 by 0.02%. Revenue came in at $12.59B, exceeding the estimate of $12.51B by 0.01%.
Abbott Laboratories has beaten EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, Abbott Laboratories has averaged an EPS surprise of 0.01% and a revenue surprise of 0.01%.
Earnings Date
Oct 14
EPS Estimate
$1.420
Quarterly Revenue Estimate
$12.97B
Annual Revenue
$46.59B
as of Jun 30
Abbott Laboratories Earnings History
Analyze the earnings history of Abbott Laboratories using advanced sorting and filters.
Abbott Laboratories (ABT) Earnings Per Share
The chart below shows Abbott Laboratories's reported EPS compared to analyst estimates over recent quarters.
Abbott Laboratories (ABT) Revenue
The chart below shows Abbott Laboratories's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Abbott Laboratories (NYSE:ABT) reporting earnings?
Abbott Laboratories (ABT) is scheduled to report earnings on October 14, 2026. The last reported earnings were for reported on July 16, 2026 for Q2.
What were the latest earnings per share (EPS) for Abbott Laboratories (NYSE:ABT)?
The Actual EPS was $1.31, which beat the estimate of $1.28.
What were Abbott Laboratories’s (NYSE:ABT) revenues?
The Actual Revenue was $12.59B, which beat the estimate of $12.51B.
